Pelion in the RESPECT Index
Pelion S.A., as the first company from the healthcare sector, has been included in the prestigious RESPECT Index of socially responsible companies listed on the Warsaw Stock Exchange. The index comprises businesses managed in a sustainable and responsible manner, offering highly attractive investment opportunities.
Having met the exacting criteria, Pelion S.A. found itself among 20 companies that successfully passed an audit for inclusion in the 6th edition of the RESPECT Index. The assessment process, which was divided into several stages, included a detailed analysis of the level and degree of comprehensiveness of measures taken by a company for the benefit of its stakeholders. The areas under evaluation included management strategy and methods, labour and environmental policies, as well as market- and customer-oriented initiatives.
On January 24th, an official certificate-giving ceremony was held at the Warsaw Stock Exchange. Jacek Dauenhauer, Vice-President of the Management Board, accepted the honour on behalf of Pelion S.A.
“We regard the inclusion in the RESPECT Index as recognition of the efforts we have taken to date for the benefit of all our stakeholder groups. Our presence in the index demonstrates that Pelion Healthcare Group meets the highest CSR standards,” said Jacek Dauenhauer.
The incorporation of Pelion S.A. in the RESPECT Index coincided with the 15th anniversary of the Company's first listing. The Company, then operating under the name of Medicines S.A., was floated in February 1998.
Companies listed on the WSE as part of the RESPECT Index are subject to detailed, rigorous audits every six months. Those that qualify for inclusion in the index are businesses with the highest liquidity, leaders in corporate governance, corporate disclosure and investor relations, as well as entities with outstanding track records of initiatives undertaken for the benefit of the environment, society and employees.
The RESPECT INDEX provides a real reference for investors, as it guarantees investment in companies with sound liquidity positions and the best management standards. The first tools of this type were the Dow Jones Sustainability Indexes launched in 1999. Similar indices on global stock exchanges comprise businesses holding the lead in terms of ethical business conduct, environmental protection and respect for human rights.
For further details please contact:
Renata Borkowska-Kubiak
Press Officer for Pelion S.A.
Tel. (+48 42) 200 79 19
Fax (+48 42) 613 35 35
Mobile (+48) 785 858 991
E – mail: renata_borkowska-kubiak@pelion.eu
Pelion S.A., formerly Polska Grupa Farmaceutyczna S.A., has operated on the market for twenty-one years. Initially, it was a local pharmaceutical wholesaler. In 1998, the Company shares were floated on the Warsaw Stock Exchange. Proceeds from the initial public offering fuelled the Company’s dynamic growth and allowed it to embark on consolidation of the pharmaceutical wholesale market. Since its floatation, the Company has secured a top position among domestic distributors of medicinal products. Today, Pelion Healthcare Group is one of the largest groups operating on the healthcare markets in Poland and Lithuania. Its services cover all market segments (wholesale, retail and sale to hospitals) and are targeted at individual patients, pharmacies, hospitals and manufacturers. As a holding company, Pelion S.A. oversees all areas of the Group’s operations, which are conducted by PGF Hurt Sp. z o.o. (wholesale), PGF Urtica Sp. z o.o. (sale to hospitals), CEPD N.V. (retail sale), and Pharmalink Sp. z o.o. (services for manufacturers).
On January 24th, an official certificate-giving ceremony was held at the Warsaw Stock Exchange. Jacek Dauenhauer, Vice-President of the Management Board, accepted the honour on behalf of Pelion S.A.
“We regard the inclusion in the RESPECT Index as recognition of the efforts we have taken to date for the benefit of all our stakeholder groups. Our presence in the index demonstrates that Pelion Healthcare Group meets the highest CSR standards,” said Jacek Dauenhauer.
The incorporation of Pelion S.A. in the RESPECT Index coincided with the 15th anniversary of the Company's first listing. The Company, then operating under the name of Medicines S.A., was floated in February 1998.
Companies listed on the WSE as part of the RESPECT Index are subject to detailed, rigorous audits every six months. Those that qualify for inclusion in the index are businesses with the highest liquidity, leaders in corporate governance, corporate disclosure and investor relations, as well as entities with outstanding track records of initiatives undertaken for the benefit of the environment, society and employees.
The RESPECT INDEX provides a real reference for investors, as it guarantees investment in companies with sound liquidity positions and the best management standards. The first tools of this type were the Dow Jones Sustainability Indexes launched in 1999. Similar indices on global stock exchanges comprise businesses holding the lead in terms of ethical business conduct, environmental protection and respect for human rights.
For further details please contact:
Renata Borkowska-Kubiak
Press Officer for Pelion S.A.
Tel. (+48 42) 200 79 19
Fax (+48 42) 613 35 35
Mobile (+48) 785 858 991
E – mail: renata_borkowska-kubiak@pelion.eu
Pelion S.A., formerly Polska Grupa Farmaceutyczna S.A., has operated on the market for twenty-one years. Initially, it was a local pharmaceutical wholesaler. In 1998, the Company shares were floated on the Warsaw Stock Exchange. Proceeds from the initial public offering fuelled the Company’s dynamic growth and allowed it to embark on consolidation of the pharmaceutical wholesale market. Since its floatation, the Company has secured a top position among domestic distributors of medicinal products. Today, Pelion Healthcare Group is one of the largest groups operating on the healthcare markets in Poland and Lithuania. Its services cover all market segments (wholesale, retail and sale to hospitals) and are targeted at individual patients, pharmacies, hospitals and manufacturers. As a holding company, Pelion S.A. oversees all areas of the Group’s operations, which are conducted by PGF Hurt Sp. z o.o. (wholesale), PGF Urtica Sp. z o.o. (sale to hospitals), CEPD N.V. (retail sale), and Pharmalink Sp. z o.o. (services for manufacturers).
